PATENT CLAIM ANALYSIS

Application Number: 16075240
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "315000"]

Abstract:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.

Claim (Index 7):
The compound according to  claim 1 , wherein R 1  is\n (1) a hydrogen atom, (2) an optionally substituted C 1-6  alkyl-carbonyl group, (3) an optionally substituted C 3-10  cycloalkyl-carbonyl group, (4) an optionally substituted C 1-6  alkoxy-carbonyl group, (5) an optionally substituted C 3-10  cycloalkyloxy-carbonyl group, (6) an optionally substituted C 6-14  aryl-carbonyl group, (7) an optionally substituted C 6-14  aryloxy-carbonyl group, (8) an optionally substituted 5- to 14-membered aromatic heterocyclylcarbonyl group, (9) an optionally substituted 3- to 14-membered non-aromatic heterocyclylcarbonyl group, (10) an optionally substituted mono- or di-C 1-6  alkyl-carbamoyl group, (11) an optionally substituted mono- or di-C 3-10  cycloalkyl-carbamoyl group, (12) an optionally substituted mono- or di-C 6-14  aryl-carbamoyl group, (13) an optionally substituted C 1-6  alkylsulfonyl group, (14) an optionally substituted C 3-10  cycloalkylsulfonyl group, (15) an optionally substituted C 6-14  arylsulfonyl group, (16) an optionally substituted heterocyclyl-sulfonyl group, (17) an optionally substituted mono- or di-C 1-6  alkyl-sulfamoyl group or (18) an optionally substituted C 1-6  alkyl-carbonyl-carbonyl group;\n R 2  is a C 3-6  cycloalkyl group or a 3- to 6-membered saturated monocyclic non-aromatic heterocyclic group, each of which is optionally substituted by 1 to 3 substituents selected from \n (1) deuterium, (2) a halogen atom, (3) a hydroxy group, (4) an optionally substituted C 1-6  alkyl group, (5) a C 3-10  cycloalkyl group, (6) an optionally substituted C 1-6  alkoxy group, (7) an optionally substituted C 6-14  aryl group, (8) a C 6-14  aryloxy group, (9) a tri-C 1-6  alkylsilyloxy group, (10) an optionally substituted 5- to 14-membered aromatic heterocyclic group and (11) an optionally substituted C 6-14  aryl-carbonyl group; and\n R 3  is a C 1-6  alkyl group optionally substituted by 1 to 3 substituents selected from a halogen atom and a C 6-14  aryl group, or a mono- or di-C 1-6  alkylamino group, or a salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.39535
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16049359', '15933889', '14779347', '14898633', '14566157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8196935822093219
- 35 USC 102 Novelty (BERT): 0.5326786012988852
- Combined Prediction Score: 0.7909920841182781
- Mean Citation Score: 359.833626
- Max Citation Score: 364.97223
- Similarity Product: 308.3626920762813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test